If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript-enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
GASTROENTEROLOGY
ISSN 2054-6203 Vol 7.1 • December 2018 • europeanmedical-journal.com
INSIDE
Review of
UEG WEEK 2018
Vienna, Austria
Contents
EDITORIAL BOARD 4
WELCOME 7
FOREWORD 9
01 CONGRESS REVIEW
Review of UEG Week 2018, held in Vienna, Austria, 20th–24th 12
October 2018
BUYER'S GUIDE 28
02 INTERVIEWS WITH EMJ GASTROENTEROLOGY EDITORIAL BOARD
Prof Oliver Grundmann
GASTROENTEROLOGY ISSN 2054-6203
Contents EDITORIAL BOARD
"On behalf of the EMJ team, I am proud to
Editorial Board Editor-in-Chief Dr Sorin T. Barbu
Aims and Scope The European Medical Journal (EMJ)
EMJ Gastroenterol. Chief Executive Officer Spence
Welcome On behalf of the EMJ team, I am p
Share your knowledge with the world.
Foreword Dear colleagues and friends of gastroent
Available now.
Inside this eJournal: Congress Review + Review
Congress Review Review of the 26th
> The exhibition space spanned a vast 5,084 m2, w
More Screening Required for Young-Onset Colorecta
many European screening programmes are only avail
The researchers enrolled 46 patients wi
Link Between Black Death and Crohn’s Disease Reve
an extent that, even now, is only just becoming f
20 GASTROENTEROLOGY • December 2018
Austria Center Vienna Home of UEG Week 2018
This year, the awards were split between re
Gene Expression Analysis in Inflammatory Bowel Dis
Dr Nicolien Schepers, who presented the
in many different ways,” she commented.
Remarkable leader and UEG President 2012- 20
The first question the experts were asked was whet
Buyer's Guide > 3-D MATRIX > 3D SYSTEMS SIMBIONIX
> MEDI-GLOBE GMBH/ ENDO-FLEX GMBH > MEDITALIA
Interviews Delve into the minds of our esteemed
Some of your medical training took place in Münst
standards of care. Furthermore, it allows clinica
healthcare providers to optimise treatmen
Dr Christoph Gubler University Hospital Zurich,
negative pressure in the cavities. Sponges have t
in the field and the scope of specialisatio
using coronary artery calcification as a
describe as ‘mini impromptu journal clubs’,
More of a visual learner?
A Worldwide Perspective on Diagnosis and Mana
diversity (dysbiosis) may adversely influence colo
Diverticulosis Diverticular disease
colonic segments, as well as genetic and dietary
abdominal pain or tenderness during inpatient car
Role of Rifaximin in the Manage
In the TARGET3 study,53 in which patients with IB
interdisciplinary consensus on diagnostics and tr
Colorectal Dis. 2003;18(1):55-62. 50. Colecchia
Interact with us on social media.
The Emerging Treatment Landscape
Citation: EMJ Gastroenterol.
Table 1: Approaches to address unmet needs in infl
phase of disease, is essential. During this phase
Table 2: Approved adalimumab and infliximab biosim
The results of a survey conducted by the E
Tailored information, including permitted Conditi
in inflammatory bowel disease and 24. othe
Are We Ready to Change the Course of Inflammat
Meeting Summary The objectives of the symposium w
Early initiation of disease-modifying age
The key concept in CD management for the next dec
protein (CRP) and faecal calprotectin were n
from endoscopy. Treatment is initiated and,
Case 2 was asymptomatic, but the calprotectin lev
Disease duration prior to initiation of treatment
diseases. Early intervention and personalised ris
Abstract Reviews Discover the latest research a
patients is of potential harm to the intestine. I
References 1. Cohen JE. Human population: Th
captured. The clinical response was assessed
References 1. Siegel RL et al. Cancer statis
Table 1: Independent predictors of hepatocellular
current antiviral therapy. J Hepatol. 2015;62(4):
using antibodies against SA100A4 and GPC3 on the
Bowel Preparation for Small Bowel Ca
examination was well-tolerated, safe, and di
standardised balloon expulsion test;5 in mos
common practice.1 However, recent studies
Conversely, as shown in this study, many cases of
lesion found using the Portsmouth protocol,
Mechanisms Underlying Chemotherapy-Associated
is a key factor behind gastrointestinal toxicity
INITIATION GENERATION OF SIGNALS SIGNAL AMPLIFIC
in preventing mucositis development.1
with irinotecan. Treatment of mice with an
was markedly increased in irinotecan-treated
development.33,53 TLR4 expression in the gut
Table 1: Therapeutic targets that have been teste
6. Sonis ST. New thoughts on the
associated symptomatic stomatitis: Role of Herpes
Adenoma and Malignant Colorectal Polyp:
group, with the prevalence increasing with age.5
A Figure 1A: Features of low-grade epithelial dy
Levene et al.11 conducted a study including 235 a
HIGH-RISK HISTOLOGICAL FACTORS FOR REGIONAL AND D
important in predicting outcome. For example, Hag
define budding, including the use of immunostains;
Figure 2: The RCPath dataset for reporting of loc
The Recognition of Muscularis Mucosa in Invasive
> Mucosal prolapse changes often present. > Absen
colorectal cancer. Gastroenterology. 2012;143(3):
Non-Cardiac Chest Pain: A Review of Environmental
a broad overview of biomarkers of GORD-associated
systematic reviews, or clinical s
Differential diagnosis Gastr o intestinal
visceral pleura receptors that are connected
Table 1: Biomarkers of non-cardiac chest pain due
Table 1 continued. Study Country Population
Elevated levels of matrix-metalloproteinase
FDNY firefighters to determine its potential t
30. Nolan A et al. MMP-2 and TIMP-1
Pathology and Pathogenesis of Radiation B
RBD results from therapy-induced damage t
estimated that the majority of patients wil
thus aggravating the disease. The timing of
phases depending on the tissue type that is predo
A B Figure 2: A) Crypt distortion and fibrosis of
Clin Oncol (R Coll Radiol). 2011;23(8):552-7. 7.
Prevention of Infantile Colic Using Probiotics
theories, such as inadequate maternal–infant
An adult human intestine contains about
Hippocampus Amygdala Emotion Stress Limbic syst
Table 1: Comparison of studies examining the use
Day 7. At the end of 30 days, treatment success w
In the deficit of other efficacious treatmen
42. Carabotti M et al. The gut-brain
Never miss an update again. J